Rahul Dwivedi | Access leader, Serious Bacterial Infections
Global Antibiotic Research & Development Partnership (GARDP)
Rahul is responsible for developing and executing strategies to enable access for life-saving antibiotics in LMICs. Overall responsibility for GARDP's portfolio of antibiotics targeted at saving patients suffering from life threatening sepsis caused by CR bacterial infections.
Appearances:
Day 1 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 10:15
Keynote panel: Challenges and opportunities for access and stewardship in low-income countries
In a conversation with Oliver Barns of the FT, scientific and medical leaders from GSK and GARD-P will discuss the challenge of access and stewardship for antibiotics in the context of lower-income country settings. They will define the components of the problem and share how their organizations are approaching this challenge as well reasons to be optimistic for a better future.
Sponsored by GSK
Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 13:50
Panel: Economic & procurement tools to improve antibiotic access: SECURE and other initiatives
Economic & procurement tools to improve antibiotic access: SECURE and other initiatives: The objective of this panel session is to assess the progress made in developing and implementing effective policy options to improve the procurement of new and existing antibiotics, with the goals of enhancing sustainable access, preventing overuse, and ultimately spurring research and development.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events